 |
인쇄하기
취소
|
Drug industry to oppose substitutive dispensing restriction only for proven drugs of bio-equivalency
The pharmaceutical industry strongly opposed, as saying "Nonsense".
against the issue of restricting the substitutive dispensing only for the drugs already proved with its bio-equivalency test in the negotiation between the government and the medical community.
The industry recalled the earlier government policy of which the substitutive dispensing prescribed drugs for other analogues at ph...
against the issue of restricting the substitutive dispensing only for the drugs already proved with its bio-equivalency test in the negotiation between the government and the medical community.
The industry recalled the earlier government policy of which the substitutive dispensing prescribed drugs for other analogues at ph...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.